Brief: Novabay Pharmaceuticals Completes The Sale Of Its Eyecare Business To Prn
23/01/2025 13:03
Jan 23 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS COMPLETES THE SALE OF ITS EYECARE
BUSINESS TO PRN AND FURTHER ADJOURNS ITS SPECIAL MEETING OF
STOCKHOLDERS ON DISSOLUTION PROPOSAL
Source text: ID:nBwbDp7mRa
Further company coverage: NBY.A
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing